Finasteride/Minoxidil (Beijing Dayspring Pharmaceutical Technology)

非那雄胺/米诺地尔（北京辰光医药科技有限公司）

Report date: 2025/08/01 14:22:14

Base Information

Drug NameFinasteride/Minoxidil (Beijing Dayspring Pharmaceutical Technology)
Drug Alias NameCG2001CG-2001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitorsVoltage-gated potassium channel agonists
TargetsSteroid 5 alpha reductaseVoltage-gated potassium channel
Therapy Area/IndicationsAlopecia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Dayspring Pharmaceutical Technology Co LtdDayspring (Tianjin) Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDayspring (Tianjin) Pharmaceutical Co LtdBeijing Dayspring Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAlopecia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A